PHARMABLOCK

300725
40.065.59% ( -2.37 )
Delay Closed: Nov 18, 15:00:00

Valuation

Current ValuationThe current P/E ratio is 44.78, within the reasonable range, cheaper than 33.29% of the time in the past 3 years, and the industry ranks 97/222, the industry Median 21.64.

44.78xP/E
Stock price¥42.43Earnings per share¥0.95

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 21.64x
015304560

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 21.64x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
600436SHZZPZH
59.96x17.36%¥78.96B
002653SZHaisco
47.26x572.55%¥61.61B
002821SZAsymchem
44.84x16.47%¥53.11B
300765SZCSPC Innovation
45.59x628.47%¥45.26B
002294SZSalubris
41.58x29.31%¥29.73B
300199SZHYBIO
48.79x--¥19.61B
603858SHBUCHANG PHARMA
55.34x--¥15.60B
301569SZNOVAST
47.93x--¥14.92B
002626SZKingdomway
43.19x26.67%¥10.06B
300725SZPHARMABLOCK
44.78x18.18%¥9.92B
600851SHHX GROUP
50.37x--¥9.62B
600789SHLKPC
52.15x--¥7.11B
603538SHMenovo
58.92x--¥6.51B
688553SHHUIYU PHARMACEUTICAL
49.04x--¥6.33B
002390SZxinbang phar.
41.44x--¥5.73B
688799SHHWPC
49.82x24.46%¥5.68B
301393SZHighfine
45.53x--¥5.62B
002907SZPharscin Pharma
55.59x--¥5.22B
002940SZALK
40.47x--¥4.47B
301281SZKeyuan Pharma
52.70x--¥3.71B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.